Ad is loading...
AVIR
Price
$3.22
Change
-$0.09 (-2.72%)
Updated
Nov 15 closing price
107 days until earnings call
INZY
Price
$3.13
Change
-$0.31 (-9.04%)
Updated
Nov 15 closing price
123 days until earnings call
Ad is loading...

AVIR vs INZY

Header iconAVIR vs INZY Comparison
Open Charts AVIR vs INZYBanner chart's image
Atea Pharmaceuticals
Price$3.22
Change-$0.09 (-2.72%)
Volume$313.82K
CapitalizationN/A
Inozyme Pharma
Price$3.13
Change-$0.31 (-9.04%)
Volume$474.4K
CapitalizationN/A
AVIR vs INZY Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AVIR vs. INZY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a StrongSell and INZY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (AVIR: $3.22 vs. INZY: $3.13)
Brand notoriety: AVIR and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 153% vs. INZY: 185%
Market capitalization -- AVIR: $271.97M vs. INZY: $200.75M
AVIR [@Biotechnology] is valued at $271.97M. INZY’s [@Biotechnology] market capitalization is $200.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, AVIR is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 2 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • AVIR’s TA Score: 2 bullish, 5 bearish.
  • INZY’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, INZY is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а -8.00% price change this week, while INZY (@Biotechnology) price change was -22.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

AVIR is expected to report earnings on Mar 04, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVIR($272M) has a higher market cap than INZY($201M). AVIR YTD gains are higher at: 5.574 vs. INZY (-26.643). INZY has higher annual earnings (EBITDA): -82.82M vs. AVIR (-203.66M). AVIR has more cash in the bank: 502M vs. INZY (145M). AVIR has less debt than INZY: AVIR (2.03M) vs INZY (46.7M). AVIR (0) and INZY (0) have equivalent revenues.
AVIRINZYAVIR / INZY
Capitalization272M201M135%
EBITDA-203.66M-82.82M246%
Gain YTD5.574-26.643-21%
P/E RatioN/AN/A-
Revenue00-
Total Cash502M145M346%
Total Debt2.03M46.7M4%
FUNDAMENTALS RATINGS
AVIR: Fundamental Ratings
AVIR
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVIRINZY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 14 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ENPIX46.99-0.17
-0.36%
ProFunds UltraSector Energy Investor
JHUJX29.45-0.23
-0.77%
JPMorgan Emerging Markets Equity R2
KTRSX10.00-0.08
-0.79%
DWS Global Income Builder S
AIMOX17.37-0.15
-0.86%
AQR International Momentum Style I
VCULX16.88-0.43
-2.48%
VALIC Company I Growth

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with VIR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-2.72%
VIR - AVIR
48%
Loosely correlated
-7.29%
INZY - AVIR
47%
Loosely correlated
-8.89%
HEPA - AVIR
47%
Loosely correlated
+2.26%
AXON - AVIR
46%
Loosely correlated
-0.86%
MGTX - AVIR
45%
Loosely correlated
-2.41%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-8.89%
BEAM - INZY
58%
Loosely correlated
-8.59%
FATE - INZY
53%
Loosely correlated
-2.88%
PGEN - INZY
50%
Loosely correlated
-7.11%
DNLI - INZY
50%
Loosely correlated
-11.95%
NTLA - INZY
50%
Loosely correlated
-7.61%
More